Lesson plan

LispMe

LispMe is an interpreter for the Scheme programming language developed by Fred Bayer for Palm OS PDAs. It is free software released under the GNU General Public License. It is reasonably close to standard Scheme but is not fully R5RS compliant. Scheme source programs can be stored in Palm OS memopad format while Scheme sessions, are stored in Palm OS PDB database files and can be interrupted and restarted. There is some support for Palm OS user interface primitives. LispMe also provides some database support. LispMe sessions can be given a "starter icon", which appears in the Applications menu, enabling the session to be run as a Palm Pilot application. The product ended development in August 2008, but is fairly complete and quite robust.

Back to article

Article summary

LispMe is an interpreter for the Scheme programming language developed by Fred Bayer for Palm OS PDAs. It is free software released under the GNU General Public License. It is reasonably close to standard Scheme but is not fully R5RS compliant. Scheme source programs can be stored in Palm OS memopad format while Scheme sessions, are stored in Palm OS PDB database files and can be interrupted and restarted. There is some support for Palm OS user interface primitives. LispMe also provides some database support. LispMe sessions can be given a "starter icon", which appears in the Applications menu, enabling the session to be run as a Palm Pilot application. The product ended development in August 2008, but is fairly complete and quite robust.

Key claims

No claims recorded.

Discussion questions

  1. Summarise the article in your own words. Which single claim would you verify first, and why?
  2. Which claim in this article is most likely to be revised as the sources update? How would you check its current status?
  3. If two sources disagreed about one of these facts, what would you need in order to trust one over the other?

Bibliography

No sources recorded.

Key claims and bibliography are generated from the same tracked claims and sources as the article page.